Tirzepatide is a groundbreaking treatment agent for individuals struggling type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://fannieyjkw226406.estate-blog.com/39437911/tirzepatide-a-novel-glp-1-and-gip-receptor-agonist